Clinical trial

Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi

NCT00177086 · University of Minnesota, Other · Completed

Key facts

NCT number NCT00177086
Title Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi
Official title Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi
Lead sponsor University of Minnesota, Other
Collaborators Manoj, Monga, M.D.
Status Completed
Phase Phase 3
Study type Interventional
Conditions Kidney Calculi, Ureteral Calculi, Colic
Intervention type Other
Interventions Alfuzosin Hydrochloride
Enrollment 76
Start date Sep 1, 2005
Primary completion Jan 1, 2008
Completion Jan 1, 2008
First posted Sep 15, 2005
Last update posted Mar 18, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies